DOCKETS ENTERED on 09/11/01

Food and Drug Administration, Dockets Management Branch, 5630 Fishers Lane - Room 1061- HFA-305, Rockville, MD, 20852; 301-827-6860; Fax 301-827-6870 [E-mail Us]

DOCKETS ENTERED on September 11, 2001

TABLE OF CONTENTS

Hyper links are part of the Docket title - not all dockets/documents are linked

NOTE: Documents received by the Dockets Management Branch "MAY" be posted on the Internet. PLEASE DO NOT include personal identifying information, i.e. date of birth, social security number, etc., in your correspondence.

[FDA DOCKETS PAGE] [FDA HOME PAGE] [ ITEM CODES ]

96P-0157 Refrain from granting exclusivity to NDAs for Fexofenadine *
96P-0418 Reduce the Precense of Salmonella Enteritidis in Shell Eggs *
97P-0102 Drug acetaminophen tend to deplete glutathione for HIV-infec *
97P-0197 Require that warning labels about risks of salmonella enteri *
97S-0163 Dietary Supplements, Courtesy Letters (Letters of Objection) *
98N-1230 Labeling of Shell Eggs;Shell Eggs: Refrigeration of Shell *
99P-2077 Reg/Guide to Label Medical Devices contain'g Phthalate Plast *
01D-0262 Automated Testing Instruments used in Blood Establishments *
01P-0117 Rescind Approval of Solid Oral Dosage form of Metaxalone *
01P-0120 Ban Unsafe IV Catheters and other Devices *
01P-0122 To Remove False and Deceptive Labeling for Transderm Scop *

96P-0157 Refrain from granting exclusivity to NDAs for Fexofenadine

LET 3 HFD-5 to Olsson Frank & Weeda PC Vol#: 1

96P-0418 Reduce the Precense of Salmonella Enteritidis in Shell Eggs

C 826 Mary Ann Bouse Vol#: 31

97P-0102 Drug acetaminophen tend to deplete glutathione for HIV-infec

C 4 Dept of Genetics, Stanford University Vol#: 1

97P-0197 Require that warning labels about risks of salmonella enteri

C 827 Mary Ann Bouse Vol#: 30

97S-0163 Dietary Supplements, Courtesy Letters (Letters of Objection)

LET 537 HFS-810 to NBTY Inc Vol#: 15

LET 538 HFS-810 to M K Health Food Distributor i Vol#: 15

LET 539 HFS-810 to Source Naturals Inc Vol#: 15